Hexamethylmelamine treatment of sarcomas and lymphomas.
D000293:Adolescent; D000328:Adult; D006585:Altretamine / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001859:Bone Neoplasms / Q000188:drug therapy; D002648:Child; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D012075:Remission, Spontaneous; D012509:Sarcoma / Q000188:drug therapy*; D014227:Triazines / Q000627:therapeutic use*
D014227:Triazines; D006585:Altretamine